Organon & Co (OGN)
Debt-to-equity ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 472,000 | 493,000 | 144,000 | 48,000 | -70,000 | -589,000 | -555,000 | -737,000 | -892,000 | -1,066,000 | -1,137,000 | -1,250,000 | -1,508,000 | -1,618,000 | -1,934,000 | 4,722,000 | -820,000 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — | — | — | — | — | — | 0.00 | — |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $472,000K
= 0.00
The debt-to-equity ratio for Organon & Co indicates a level of 0.00 from March 31, 2021, onwards, which implies that the company has no debt or very minimal debt compared to its equity during this period. A debt-to-equity ratio of 0.00 suggests that the company is relying more on equity financing rather than debt to fund its operations and growth. This could be a positive sign as it indicates a lower financial risk due to lower debt levels. However, it is important to note that without debt, the company may miss out on the potential tax benefits and leverage that debt can provide.
Peer comparison
Dec 31, 2024